332 related articles for article (PubMed ID: 25294046)
1. Survey of findings in patients having persistent heartburn on proton pump inhibitor therapy.
Mandaliya R; DiMarino AJ; Cohen S
Dis Esophagus; 2016 Jan; 29(1):27-33. PubMed ID: 25294046
[TBL] [Abstract][Full Text] [Related]
2. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
Anandasabapathy S; Jaffin BW
Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
[TBL] [Abstract][Full Text] [Related]
3. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
[TBL] [Abstract][Full Text] [Related]
4. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
[TBL] [Abstract][Full Text] [Related]
6. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
[TBL] [Abstract][Full Text] [Related]
7. The added diagnostic value of postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance in refractory reflux disease studied with on-therapy impedance-pH monitoring.
Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Furnari M; Martinucci I; Mirante VG; Marchi S; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27620303
[TBL] [Abstract][Full Text] [Related]
8. Convenient Method of Measuring Baseline Impedance for Distinguishing Patients with Functional Heartburn from those with Proton Pump Inhibitor-Resistant Endoscopic Negative Reflux Disease.
Yoshimine T; Funaki Y; Kawamura Y; Tamura Y; Izawa S; Ebi M; Ogasawara N; Murotani K; Sasaki M; Kasugai K
Digestion; 2019; 99(2):157-165. PubMed ID: 30179879
[TBL] [Abstract][Full Text] [Related]
9. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time.
Frazzoni L; Frazzoni M; de Bortoli N; Tolone S; Furnari M; Martinucci I; Bertani H; Marchi S; Conigliaro R; Fuccio L; Savarino V; Savarino E
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28543861
[TBL] [Abstract][Full Text] [Related]
10. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
[TBL] [Abstract][Full Text] [Related]
11. Lower pH values of weakly acidic refluxes as determinants of heartburn perception in gastroesophageal reflux disease patients with normal esophageal acid exposure.
de Bortoli N; Martinucci I; Savarino E; Franchi R; Bertani L; Russo S; Ceccarelli L; Costa F; Bellini M; Blandizzi C; Savarino V; Marchi S
Dis Esophagus; 2016 Jan; 29(1):3-9. PubMed ID: 25212408
[TBL] [Abstract][Full Text] [Related]
12. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
13. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
[TBL] [Abstract][Full Text] [Related]
14. Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.
Clayton SB; Rife CC; Singh ER; Kalbfleisch JH; Castell DO
Dis Esophagus; 2012; 25(8):682-6. PubMed ID: 22292567
[TBL] [Abstract][Full Text] [Related]
15. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
16. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
Frazzoni M; Conigliaro R; Mirante VG; Melotti G
Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
[TBL] [Abstract][Full Text] [Related]
17. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
[TBL] [Abstract][Full Text] [Related]
18. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
[TBL] [Abstract][Full Text] [Related]
19. Signal detection theory approach to gastroesophageal reflux disease: a new method for symptom analysis of impedance-pH data.
Giral A; Kurt R; Yeğin EG; Yeğin K
Dis Esophagus; 2014 Apr; 27(3):206-13. PubMed ID: 23795569
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
